Exec-Edge – Page 3

FDA Recognizes March Biosciences’ MB-105 with RMAT Status

By Daniella Parra March Biosciences said that the FDA granted regenerative medicine advanced therapy its first-in-class CD5-targeted CAR-T cell therapy for relapsed or refractory CD5-positive T-cell lymphoma. The designation is based on encouraging early Phase 2 data showing clinical activity and...

Cherry-Sweet Yield Flags Valuation Upside at CHMI – Quarterly Update Report

Download the Complete Report Here By Brandon Hornback Cherry Hill Mortgage Investment Corp. (NYSE: CHMI) delivered stable performance in the third quarter, just as much friendlier market conditions should clear the way for valuation upside. Core net interest income edged...

Cherry Hill Mortgage: Sweeter Yield Flags Valuation Upside – Downloadable Quarterly Report

Subscribe to our Weekly Newsletter to Receive All Research Contact: Executives-Edge.com Rayk@capmarketsmedia.com

The ONE Group Hospitality: Lighting Up the Holidays – Quarterly Update Report

Download the Complete Report Here By Brandon Hornback The ONE Group Hospitality, Inc. (NASDAQ: STKS) is on the verge of a holiday season to celebrate. The owner of Benihana reported a modest sales decline in the September quarter, reflecting the...

The ONE Group Hospitality: Lighting Up the Holidays – Downloadable Quarterly Report

Subscribe to our Weekly Newsletter to Receive All Research Contact: Executives-Edge.com Rayk@capmarketsmedia.com

Twin Hospitality: Time to Step Into the Lodge for Big Returns – Quarterly Update Report

Download the Complete Report Here By Brandon Hornback Twin Hospitality Group Inc. (NASDAQ: TWNP) is sharpening its focus and tightening its playbook — with results beginning to show. Revenue in the quarter through September held firm at $82.3 million, down...

Twin Hospitality: Lodge Conversions in Motion and Set to Deliver Big Returns – Downloadable Quarterly Report

Subscribe to our Weekly Newsletter to Receive All Research Contact: Executives-Edge.com Rayk@capmarketsmedia.com

Aurora Cannabis: Medical Sales Boom Worldwide, Cash Flow to Swing Positive – Quarterly Update Report

Download the Complete Report Here By Brandon Hornback Aurora Cannabis Inc. (NASDAQ: ACB) smoked another quarter, led by top-line growth, profitability, and disciplined capital allocation. And in fresh news, there’s positive cash flow right around the corner. Take a hit...

Aurora Cannabis: Medical Sales Boom Worldwide, Cash Flow to Swing Positive – Downloadable Quarterly Report

Subscribe to our Weekly Newsletter to Receive All Research Contact: Executives-Edge.com Rayk@capmarketsmedia.com

Vinson & Elkins Advises NuVista Energy on Acquisition by Ovintiv Inc.

By Karen Roman Vinson & Elkins said it advised NuVista Energy Ltd. (TSX: NVA) in its definitive arrangement with Ovintiv Inc. (NYSE: OVV) and Ovintiv Canada ULC. The transaction values NuVista at approximately $3.8 billion CAD, including NuVista’s net debt,...